Clinical trial for Parkinson Disease
Official title Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
ClinicalTrials.gov ID: NCT06540989
What this study is testing
- What it's testing
- The study wants to know whether this feedback improves how understandable speech is and whether it increases social participation for people with Parkinson's disease.
- Who it's for
- Adults who have Parkinson's disease.
- What's involved
- Participants will have 2‑4 in‑person speech assessments, then do home speech exercises four days a week for four weeks using a phone and computer. Four of those sessions are monitored online by a speech‑language pathologist, and the rest are done independently. After treatment, they return for two lab assessments and again six months later.
- Time commitment
- The study lasts about six months, with a four‑week home treatment period and three lab visits (baseline, post‑treatment, and six‑month follow‑up).
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- They are 50-80 years old,
- They have a medical diagnosis of PD,
- They are within stages I-IV of Hoehn \& Yahr Scale,
- Their antiparkinsonian medication schedule is stable,
- They present with mild to moderate dysarthria,
You likely can't join if
- Present with atypical parkinsonism at the time of screening (or other neurological condition),
- Underwent neurosurgery treatment (DBS),
- Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
- Present with any speech or voice pathology that is unrelated to PD.
See the full eligibility criteria
- They are 50-80 years old,
- They have a medical diagnosis of PD,
- They are within stages I-IV of Hoehn \& Yahr Scale,
- Their antiparkinsonian medication schedule is stable,
- They present with mild to moderate dysarthria,
- They score ≥ 25 in the MMSE,
- They score ≤ 24 in the BDI-III.
- Present with atypical parkinsonism at the time of screening (or other neurological condition),
- Underwent neurosurgery treatment (DBS),
- Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
- Present with any speech or voice pathology that is unrelated to PD.
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.